BioSpace News Archive

Designation for investigational new drug, HTD1801, for the treatment of patients with nonalcoholic steatohepatitis

Teva Pharmaceutical Industries today announced the release of limited doses of the FDA-approved generic version of EpiPen®1 (epinephrine injection, USP) Auto-Injector, 0.3 mg, in the US. Teva’s generic version of the EpiPen Jr® (epinephrine injection, USP) Auto-Injector, 0.15 mg, and an additional supply of Teva’s generic version of the EpiPen® (epinephrine injection, USP) Auto-Injector, 0.3 mg is expected in 2019.

Versant Health, a leading national managed eye health and vision plan company, has partnered with Transitions Optical to create a Vision Loss Simulator to help people see how failing eye health can impact your vision.

Cell-specific coatings for improved in vitro research

23% MORE ACA plans to cover abortion in 2019, pro-life Americans now have a choice in a non-insurance option, healthcare sharing

Cannabics Pharmaceuticals Inc. today announced that Mr. Eyal Barad, CEO, will be presenting at the LD Micro Main Event.

Launching in tandem with the 30th Anniversary of World AIDS Day, the campaign aspires to change public perception of HIV prevention and treatment

Bridgeway Wellness Group, LLC has opened the Bridgeway Institute - Kentucky.

Specialty teleradiology company finds ideal match for its business model

Cardinal Health introduces approach to address sustainable cost control